A phase II study of gemcitabine in combination with oxaliplatin as first line chemotherapy in patients with inoperable biliary tract adenocarcinoma

被引：0
|
作者：
Kim, H. [1 ]
Lee, S. [2 ]
Bae, S. [3 ]
Kim, C. [1 ]
Lee, N. [2 ,3 ]
Lee, K.
Park, S. [1 ]
Won, J. [1 ,2 ]
Hong, D.
Park, H. [2 ]
机构：
[1] Soonchunhyang Univ Hosp, Puchon, South Korea
[2] Soonchunhyang Univ Hosp, Seoul, South Korea
[3] Soonchunhyang Univ Hosp, Cheonan, South Korea
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71062-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3559
引用
收藏
页码：277 / 277
页数：1
相关论文
共 50 条
  • [31] Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma
    Mok, Tony
    Yang, Tsai-Shen
    Chao, Yee
    Wang, Cheng-Hsu
    Liu, Mei-Ching
    Kang, Yoon Koo
    Kang, Won Ki
    Kim, Jun Suk
    Wang, Yajie
    Leung, Thomas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (02) : 95 - 100
  • [32] A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma
    Lin, LL
    Picus, J
    Drebin, JA
    Linehan, DC
    Solis, J
    Strasberg, SM
    Tan, B
    Thorstad, WL
    Myerson, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (03): : 234 - 241
  • [33] Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma:: a GERCOR study
    André, T
    Tournigand, C
    Rosmorduc, O
    Provent, S
    Maindrault-Goebel, F
    Avenin, D
    Selle, F
    Paye, F
    Hannoun, L
    Houry, S
    Gayet, B
    Lotz, JP
    de Gramont, A
    Louvet, C
    ANNALS OF ONCOLOGY, 2004, 15 (09) : 1339 - 1343
  • [34] Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness
    Sung Yong Oh
    Chi Young Jeong
    Soon Chan Hong
    Tae Hyo Kim
    Chang Yoon Ha
    Hyun Jin Kim
    Gyeong-Won Lee
    In Gyu Hwang
    Joung Soon Jang
    Hyuk-Chan Kwon
    Jung Hun Kang
    Investigational New Drugs, 2011, 29 : 1066 - 1072
  • [35] Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness
    Oh, Sung Yong
    Jeong, Chi Young
    Hong, Soon Chan
    Kim, Tae Hyo
    Ha, Chang Yoon
    Kim, Hyun Jin
    Lee, Gyeong-Won
    Hwang, In Gyu
    Jang, Joung Soon
    Kwon, Hyuk-Chan
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 1066 - 1072
  • [36] Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma
    Buemi, Barbara
    Marabello, Grazia
    Gnani, Alessandro
    Lupo, Giuseppe
    Orizzonte, Giovanna
    Pettineo, Giuseppe
    Iacono, Carmelo
    Altavilla, Giuseppe
    ANNALS OF ONCOLOGY, 2005, 16 : 49 - 49
  • [37] Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer
    Pressiani, Tiziana
    Balsano, Rita
    Giordano, Laura
    Milella, Michele
    Bergamo, Francesca
    Bozzarelli, Silvia
    Noventa, Silvia
    Ferrrari, Daris
    Scartozzi, Mario
    Parra, Hector Soto
    Auriemma, Alessandra
    Solda, Caterina
    Zaniboni, Alberto
    Zecchetto, Camilla
    Rizzato, Mario Domenico
    Rimassa, Lorenza
    Santoro, Armando
    EUROPEAN JOURNAL OF CANCER, 2024, 207
  • [38] Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract Carcinoma
    Hollebecque, Antoine
    Bouche, Olivier
    Romano, Olivier
    Scaglia, Elodie
    Cattan, Stephane
    Zerbib, Philippe
    Heurgue, Alexandra
    Lagarde, Stephanie
    Mariette, Christophe
    Triboulet, Jean-Pierre
    Pruvot, Francois-Rene
    Hebbar, Mohamed
    CHEMOTHERAPY, 2010, 56 (03) : 234 - 238
  • [39] A Phase II Study of Outpatient Biweekly Gemcitabine-Oxaliplatin in Advanced Biliary Tract Carcinomas
    Halim, Amal
    Ebrahim, Mohamed Awad
    Saleh, Yaser
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (02) : 217 - 224
  • [40] Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study
    Kyung Hee Lee
    Min Kyoung Kim
    Yeol Hong Kim
    Baek Yeol Ryoo
    Ho Yeong Lim
    Hong Suk Song
    Hoon Kyo Kim
    Myung Ah Lee
    Seock Ah Im
    Heung Moon Chang
    Jae Yong Cho
    Dae Young Zang
    Bong Seog Kim
    Jun Suk Kim
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 317 - 325
12345